ImpediMed Limited
IPDQF
$0.0375
$0.017587.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.81% | -12.20% | -8.44% | -1.76% | 6.04% |
| Total Depreciation and Amortization | 11.88% | 106.60% | 209.44% | 110.56% | 3.48% |
| Total Amortization of Deferred Charges | 129.99% | 51.41% | -15.16% | -15.16% | -15.16% |
| Total Other Non-Cash Items | 325.83% | -71.82% | -121.56% | -136.77% | -302.48% |
| Change in Net Operating Assets | 168.68% | 932.41% | 253.37% | 253.37% | 253.37% |
| Cash from Operations | 18.81% | -7.45% | -43.86% | -16.80% | 3.79% |
| Capital Expenditure | 28.17% | 82.38% | 100.00% | 87.51% | 79.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.49% | 62.46% | 58.38% | 52.45% | 47.91% |
| Cash from Investing | 68.42% | 63.25% | 60.38% | 54.45% | 49.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 11.53% | 6.26% | 0.86% | -5.39% | -12.24% |
| Issuance of Common Stock | -- | -100.00% | -100.00% | -99.90% | -99.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,969.35% | -16.53% | 100.00% | 98.08% | 96.28% |
| Cash from Financing | 2,840.14% | -55.21% | -101.61% | -101.64% | -101.67% |
| Foreign Exchange rate Adjustments | -231.97% | 82.47% | 334.19% | 24.44% | -74.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.43% | -120.82% | -270.37% | -340.28% | -502.36% |